Caldwell Sutter Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Sell |
3,783
-86
| -2% | -$3.3K | 0.07% | 237 |
|
|
2025
Q1 | $150K | Sell |
3,869
-173
| -4% | -$6.7K | 0.07% | 230 |
|
|
2024
Q4 | $137K | Sell |
4,042
-127
| -3% | -$4.3K | 0.06% | 244 |
|
|
2024
Q3 | $170K | Sell |
4,169
-26
| -0.6% | -$1.06K | 0.08% | 220 |
|
|
2024
Q2 | $162K | Sell |
4,195
-1,159
| -22% | -$44.6K | 0.08% | 222 |
|
|
2024
Q1 | $230K | Sell |
5,354
-938
| -15% | -$40.2K | 0.11% | 178 |
|
|
2023
Q4 | $233K | Sell |
6,292
-757
| -11% | -$28.1K | 0.12% | 166 |
|
|
2023
Q3 | $256K | Sell |
7,049
-12
| -0.2% | -$435 | 0.14% | 146 |
|
|
2023
Q2 | $252K | Buy |
7,061
+3,436
| +95% | +$122K | 0.13% | 153 |
|
|
2023
Q1 | $129K | Buy |
+3,625
| New | +$129K | 0.09% | 168 |
|